Conditional somatic mutagenesis in the mouse using site-specific recombinases.
In the last decade, site-specific recombinases (SSRs), such as Cre and Flp, have emerged as indispensable tools for the precise in vivo manipulation of the mouse genome. It is now feasible to control, in space and time, the onset of gene knockouts in almost any tissue of the mouse, thus greatly facilitating the creation of sophisticated animal models for human disease and drug development. This review describes the basic principles and current status of the SSR technology, with a focus on strategies for conditional somatic mutagenesis using the Cre/lox system and ligand-activated Cre recombinases. Practical hints for generating and analysing conditional mouse mutants will be given and exciting novel applications of the SSR technology will be discussed, such as cell fate mapping and the combined use of Cre, Flp and other biotechnological tools. It will be shown how genetic manipulation of the mouse by site-specific recombination can provide new solutions to old problems in the analysis of human physiology and pathophysiology and how it can be employed for drug discovery and development.
Feil
R
R
Interfakultäres Institut für Biochemie, Universität Tübingen, Hoppe-Seyler-Str. 4, 72076 Tübingen, Germany. robert.feil@uni-tuebingen.de
D000818:Animals; D035843:Biomedical Research / Q000379:methods; D004254:DNA Nucleotidyltransferases / Q000235:genetics / Q000378:metabolism*; D015195:Drug Design; D005818:Genetic Engineering / Q000379:methods*; D016678:Genome / Q000235:genetics; D051379:Mice; D016296:Mutagenesis
D004254:DNA Nucleotidyltransferases; C077570:Site-specific recombinase